NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/29/2025
Back to search
Official data from USPTO
STRATICYTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STRATICYTE
ST13
US500000097497577Class
1, 5, 9, 42, 44
Filing
97497577
Registration
7873790
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/29/2025
Trademark type
Word
Nice classes
1, 5, 9, 42, 44
Filing date
07/11/2022
Registration date
07/29/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/29/2025
Last transaction
07/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Toronto, ONTARIO, CA
Examiner
PULVERMACHER, TASHA NICOLE
Law office
M10
Current location
TMO LAW OFFICE 110
Holders and representatives
Holders
Proteocyte Diagnostics Inc.
Representatives
DAVID C. LEE AKIN GUMP STRAUSS HAUER & FELD LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Assays for clinical diagnostic research purposes in the field of oral cancer
Class 5
Diagnostic kits comprised of medical diagnostic reagents and medical diagnostic assays for testing tissue samples for use in oral cancer detection
Class 9
Recorded computer diagnostic platforms that incorporate an electronic imaging platform and downloadable computer software that uses a reference databaseall for use with diagnostic assays for clinical research use in the field of oral cancer
Class 42
Medical researchmedical diagnostic researchscientific research in the field of oral cancer diagnosisprognosis and treatment; providing laboratory research services in the field of protein expression relating to the treatment of oral cancer
Class 44
Medical analysis servicesprotein analysis for diagnosing and prognosing oral cancer
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/29/2025
TMBN
TTAB RELEASE CASE TO TRADEMARKS
07/03/2025
OP.T
OPPOSITION TERMINATED NO. 999999
07/03/2025
OP.D
OPPOSITION DISMISSED NO. 999999
07/03/2025
OP.I
OPPOSITION INSTITUTED NO. 999999
02/21/2024
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
11/22/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/24/2023
PUBO
PUBLISHED FOR OPPOSITION
10/24/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2023
ALIE
ASSIGNED TO LIE
09/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/26/2023
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
04/26/2023
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
04/26/2023
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
04/26/2023
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
04/26/2023
DOCK
ASSIGNED TO EXAMINER
04/25/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/28/2022
NWAP
NEW APPLICATION ENTERED
07/14/2022
Continuous trademark protection
Get notified about every new filing that threatens STRATICYTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.